Current role
Mark White
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark White
Rocket Pharmaceuticals, Inc. reported in an 8-K filed December 5, 2024 that Mark White resigned as General Manager, Commercial Affairs, effective January 1, 2025. Rocket Pharmaceuticals, Inc. reported in an 8-K filed April 4, 2023 that Mark White was appointed Chief Medical Officer, effective April 4, 2023.
“On December 2, 2024, Mark White resigned as General Manager, Commercial Affairs of Rocket Pharmaceuticals, Inc., effective January 1, 2025.”
“Additionally, on April 4, 2023, Mark White joined the Company as its new Chief Medical Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-04-04–present
-
Rocket Pharmaceuticals, Inc. (RCKT)
Proxy statement
2023-04-04–2025-01-01
-
Rocket Pharmaceuticals, Inc. (RCKT)
Proxy statement
Start not stated–2025-01-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rocket Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Gaurav Shah CEO, Board Member
- Aaron Ondrey CFO
- Carlos Garcia-Parada CFO
- John Militello CFO
- Chris Stevens COO
- Christopher Stevens COO
- Martin Wilson General Counsel
- Joseph Manhede Chief Accounting Officer
- Carsten Boess Board Member
- David P. Southwell Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.